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Angiotensin 1–7The present study attempted to evaluate the effects of chronic intermittent hypoxia (CIH) associated with sleep
restriction in hemodynamic parameters and the plasma renin–angiotensin system. Wistar–Hannover rats were
submitted to isolated CIH exposure (1000–1600 h), sleep restriction (1600–1000 h), deﬁned as 18-h paradoxical
sleep deprivation followed by 6-h sleep permission period and CIH associated to sleep restriction for 21 days.
The CIH and sleep restriction group showed a preferential increase in renal sympathetic nervous system (rSNA)
associated with a reduction in plasma angiotensin (1–7) concentrations. However, CIH-sleep restriction rats did
not modify rSNA and showed a higher angiotensin (1–7) concentration when compared to isolated CIH and
sleep restriction. These results suggest that CIH and sleep restriction impaired the cardiovascular system, and its
association to sleep loss can modify these effects by partially restoring circulating angiotensin (1–7).y, Universidade Federal de São
-04024-002, São Paulo, Brazil.
sevier OA license.© 2010 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Obstructive sleep apnea has been recognised as an independent
risk factor for hypertension (Lavie et al., 2000). However, the
mechanism by which sleep apnea can lead to hypertension and
other cardiovascular risk factors is not clear. Animal experimental data
suggests that chronic intermittent hypoxia (CIH) provides the causal
link between upper airway obstruction during sleep and sympathetic
activation during waking hours (for review see Weiss et al., 2007). It
appears that both the adrenal gland, via circulating epinephrine, and
the renin–angiotensin system (RAS) participate in diurnal arterial
hypertension in subjects with apnea (Fletcher et al., 2002).
RAS is a regulator of cardiovascular and renal systems and its
components are implicated in the control of blood pressure, body ﬂuid
homeostasis and several other cardiovascular functions (Inagami,
1994). Angiotensin-converting enzyme-2 (ACE2) efﬁciently hydro-
lyzes angiotensin II (Ang II) into angiotensin 1–7 [Ang (1–7)] (Zisman
et al., 2003; Rice et al., 2004; Santos and Ferreira, 2007), but it is
unclear how Ang (1–7) may contribute to the regulation of
cardiovascular function both physiologically and pathologically
(Ferrario, 2006). Ang (1–7), a bioactive peptide in the renin–angiotensin system, has regulatory actions counter to Ang II. Ang
(1–7) is capable of both activation of peripheral vasodilator
mechanisms and antitrophic effects mediated by inhibition of protein
synthesis (Ferrario et al., 2005; Santos and Ferreira, 2007). The
mechanisms underlying the Ang (1–7) induced vasorelaxation are the
potentiation of bradykinin-induced dilation, the stimulation of
vasodilator prostaglandins and the mediation of NO-release (for
review Schindler et al., 2007). However, in this emerging ﬁeld of Ang
(1–7) research, limited information about the functions of this
bioactive peptide currently exists, particularly in cardiovascular
responses to sleep apnea.
Isolated effects of hypoxia in animalmodels have been the subject of
extensive research. However, sleep apnea is characterised by a collapse
of upper airway breathing associated to sleep fragmentation. Recently,
our group developed a rodent model that evaluated the effects of CIH
associated with sleep restriction and provided important new insights
in thisﬁeld (Perry et al., 2007, 2008). Thus,we attempt to determine the
effects of CIH associated with sleep restriction on heart rate, blood
pressure, sympathetic nerve activity and its consequences in the plasma
renin–angiotensin system (RAS) in rats.
2. Materials and methods
2.1. Animals
Experiments were performed on 73 male adult Wistar–Hannover
rats provided by the Centro de Desenvolvimento de Modelos
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Federal de São Paulo. The animals were housed in groups of ﬁve in
standard polypropylene cages in a room maintained at 22 °C with a
12:12-h light–dark cycle (lights on at 07:00 h) and allowed free access
to food and water. All animal procedures were approved by the
University Ethics Committee (CEP no. 0490/04).
2.2. Chronic intermittent hypoxia
Chronic intermittent hypoxia (CIH) was induced in a custom-built
chamber (30×20×20 in., Oxycycler model A44X0, Biospherix, Red-
ﬁeld, NY, USA) connected to a supply of O2 and N2 gas. Sensors
measured O2 concentration, CO2 concentration (b0.01%), humidity
(40–50%) and temperature (22–24 °C). Inﬂow of O2 and N2 into the
chamber was controlled by a computer programmed to produce
cycles of 2 min of room air and 2 min of 10% O2. Rats were subjected to
this schedule during the light period (1000–1600 h). The hypoxia
procedure used in the present study reduced oxygen saturation to
about 50% (Perry et al., 2007).
2.3. Sleep restriction
Rats were individually placed on a circular platform (6.5 cm in
diameter) in a cage (23×23×29 cm) ﬁlled with water to 1 cm below
the platform level. During paradoxical sleep the rats tend to fall off the
platform and awaken due to muscular atonia. In this protocol, the rats
were kept on the platforms for 18 h (beginning at 1600 h) and
allowed to sleep for 6 h (1000 to 1600 h) every day for 21 days. This
particular time interval (1000 h to 1600 h) was chosen because it is
when paradoxical sleep is at its highest. Thus, there is a partial
compensation for the sleep loss (Machado et al., 2005). All animals
were exposed to a habituation period on the platforms for 1 h a day
for 3 days prior to the commencement of the sleep restriction
protocol.
2.4. Experimental design
Rats were randomly assigned to 4 experimental groups: 1) control;
2) CIH; 3) sleep restriction and 4) CIH associated to sleep restriction.
Rats (CIHor CIH-sleep restricted groups)were exposure to CIH between
1000 hand1600 h.TheCIH-sleep restricted ratswere submitteddaily to
sleep deprivation for 18 h (from 1600 h to 1000 h) and during the
remaining 6 h of the day (from1000 h to 1600 h), the ratswere allowed
to sleep in the hypoxia chamber. On day 21 of the experimental period
(between 0800 h and 1000 h), rats of each group were submitted to
surgical procedures (n=9 per group) or were euthanised by decapi-
tation for blood collection (n=10pergroup). Theplasmawas separated
by centrifugation for 10 min at 2000×g.
2.5. Surgical procedures
Rats were anesthetized with halothane (2% in 100% oxygen-
enriched air) and instrumented with femoral venous and arterial
catheters for drug injection and arterial pressure recording, respec-
tively. Catheters were externalized through the neck. The rats were
exposure to anesthesia during 20 min to catheterization. One hour
later, blood pressure and heart rate were recorded in awake, freely-
moving rats. Moreover, recordings were obtained from rats for 20 min
to evaluate the basal blood pressure before urethane anaesthesia. The
control group was evaluated with the same anaesthesia procedure. A
waiting period of 1 h after the catheterization surgery before
recording cardiovascular parameters was shown to provide sufﬁcient
time for recovery from the depressant effects of anesthesia. This
procedure was only elected in an attempt to promote animal well-
being, considering that during the sleep deprivation technique the
animals were placed on a circular platform that limited theirmovements. Furthermore, an additional methodological limitation
was involved in keeping the rats awake following the recovery from
anaesthesia. During this period sleep deprivation was carried out by
gentle handling, which involved tapping the cages whenever the
animals appeared drowsy.
Mean arterial pressure (MAP) and heart rate signals on freely-
moving rats were derived from pulsatile arterial pressure. All signals
were recorded on a computer-based data acquisition system (Power-
Lab system, AD Instruments, NSW, Australia).
2.5.1. Sympathetic nerve activity (SNA)
After recording blood pressure and heart rate in freely-moving rats
the animals were anesthetised with urethane (1.2–1.4 g/kg, i.v.). All
animals were artiﬁcially ventilated with oxygen-enriched air using a
respiratory pump, at a concentration that maintained end-tidal CO2
close to 4%. Rectal temperature was maintained at 37±0.5 °C by
means of a servo-controlled electric blanket. The left renal (rSNA) and
splanchnic (sSNA) sympathetic nerves were exposed through a left
retroperitoneal ﬂank incision, placed on bipolar recording silver
electrodes and covered with mineral oil. Signals from the nerves were
displayed on an oscilloscope and monitored by means of an audio
ampliﬁer. Nerve activity was also ampliﬁed (Neurolog, 20 K, UK)
using a band-pass ﬁlter (50–1000 Hz), rectiﬁed and integrated and
it is expressed as μV (Representative traces—Fig. 1; Panel C). On
completion of the experiments, the baseline noise level of sympa-
thetic nerve activity was determined after administration of hexa-
methonium bromide (30 mg/kg, i.v.). This procedure allowed
discrimination of the background noise from burst activity. The
ganglionic blockade technique is the “gold standard” procedure used
to determine the background noise level, and thus the zero baseline of
an SNA recording (Guild et al., 2009). Nerve discharge during the
experiment was expressed as spikes/second. Guild et al. (2009)
showed that the burst frequency provides important information and
an alternative for comparing the SNA signal among subjects with
different baseline microvolt levels. The mean value of spikes
frequency was obtained after removing background noise as reported
previously by Yang and Coote, 2006. Only experiments in which the
level of background noise was conﬁrmed at the end of the
experiments following hexamethonium and terminal anesthesia are
included in this report (Yang and Coote, 2006).
2.6. Blood collection
2.6.1. Angiotensin quantiﬁcation by high-performance liquid
chromatography (HPLC)
Ang I, II and 1–7weremeasured using reverse-phase HPLC (Ronchi
et al., 2007) and expressed as nmol/mL.
2.6.2. Angiotensin-converting enzyme activity (ACE)
ACE was determined ﬂuorimetrically using 1 mmol/L Z-Phe-His-
Leu as a substrate (Bachem Ltd, Switzerland). The standard assay
contained 100 mmol/L potassium buffer, pH 8.3, 100 mmol/L NaCl
and 100 μmol/L ZnSO4 and was performed at 37 °C (Friedland and
Silverstein, 1976; Casarini et al., 1997).
2.7. Statistical analysis
Values shown are expressed in mean±standard error of mean
(SEM). Student-t test was used to analyse the data. Pb0.05 was
considered statistically signiﬁcant.
3. Results
The rSNA activity was higher in CIH (pb0.04) and sleep restriction
(pb0.04) than in the control group, as shown in Fig. 1A. There was no
signiﬁcant difference between CIH-sleep restriction and control
Fig. 1. Effects of chronic intermittent hypoxia (CIH) and chronic intermittent hypoxia associated to sleep restriction (CIH-sleep restriction) on renal sympathetic nerve activity (rSNA
—Panel A) and plasma Ang (1–7) concentrations (Panel B). Representative traces of renal sympathetic nerve activity amplitude were expressed as μV (Panel C). Baseline noise level
of sympathetic nerve activity was determined after administration of hexamethonium bromide (30 mg/kg, i.v.). *pb0.05 compared to the control group and #pb0.05 compared to
the CIH and sleep restriction groups (Student-t test). Data are expressed as mean±SEM.
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rate and sSNA were not signiﬁcant (Table 1).
Ang (1–7) values were signiﬁcantly lower in the CIH (pb0.001),
sleep restriction group (pb0.001) and CIH-sleep restricted (pb0.01)
groups when compared to the control group, whereas concentrations
in the CIH-sleep restricted group were higher than in the CIH and
sleep restriction groups (pb0.001), as shown in Fig. 1B. No statistically
signiﬁcant difference was observed in plasma angiotensin I, angio-Table 1
Effects of chronic intermittent hypoxia (CIH) and chronic intermittent hypoxia associated t
(HR), splanchnic sympathetic nerve activity (sSNA) and the plasma renin–angiotensin syst
Control CIH
MAP (mm Hg) 110.5 (±3.6) 107.6 (±3.
HR (bpm) 394.2 (±17.3) 393.7 (±31
sSNA (spikes/s) 106.4 (±12.6) 110.5 (±20
Ang I (nmol/mL) 0.8 (±0.1) 0.7 (±0.
Ang II (nmol/mL) 36.4 (±2.6) 36.3 (±2.
ECA (nmol/mL/min) 78.9 (±5.4) 64.4 (±5.
Data are expressed as mean±EPM. (Student-t test was used to analyze the data; N=7–10tensin II and ACE activity among all groups. Table 1 shows all
cardiovascular and hormonal parameters evaluated in the present
study.
4. Discussion
The principal ﬁndings of our study are that CIH and sleep
restriction speciﬁcally increased rSNA activity and induced ao sleep restriction (CIH-sleep restriction) on mean arterial pressure (MAP), heart rate
em.
Sleep restriction CIH-sleep restriction
8) 104.6 (±3.6) 109.0 (±4.3)
.2) 385.0 (±22.2) 421.5 (±30.4)
.3) 106.6 (±8.1) 88.8 (±6.5)
06) 0.7 (±0.1) 0.6 (±0.07)
1) 29.0 (±1.76) 34.3 (±1.7)
9) 76.9 (±7.9) 75.7 (±4.6)
/group).
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sleep restriction did not modify rSNA activity. Whether or not CIH was
associated with sleep loss, reduced plasma Ang (1–7) concentrations
were measured compared to control rats. However, values in the CIH-
sleep restricted groups were higher than in the CIH and sleep
restriction groups.
Studies using animal models have revealed that CIH has an
important role in the stimulation of chemoreceptors (Fletcher, 2001;
Braga et al., 2006;Weiss et al., 2007; Prabhakar et al., 2007; Dematteis
et al., 2008), increasing sympathetic activity and inducing hyperten-
sion (Bao et al., 1997; Weiss et al., 2007). With regard to sympathetic
activity, CIH rats showed an increase in rSNA whereas no signiﬁcant
alteration in sSNA was observed. CIH-sleep restriction did not modify
rSNA or sSNA. Interestingly, isolated sleep restriction induced a
selective increase of rSNA activity that was accompanied by a
reduction in Ang 1–7. Thus, the data show that the paradigm of
isolated CIH and sleep restriction induced alterations in sympathetic
nerve activity, preferentially in the kidney.
After 21 days, CIH did not induce alterations in blood pressure.
Some authors suggest that the alteration of blood pressure induced by
hypoxia possesses a time-dependent effect (Prabhakar et al., 2001,
2005; Hui et al., 2003; Zoccal et al., 2007; Dematteis et al., 2008). For
instance, Hui et al. (2003), using a similar hypoxia protocol (room air
to 10% of O2) observed an increase in the blood pressure of rats after a
30-day-intermittent hypoxia period. Moreover, the alterations in
markers of the catecholamine biosynthetic pathway in peripheral
tissues that directly participate in blood pressurewere initiated after a
14-day-intermittent hypoxia period. In fact, different hypoxia proto-
cols (room air to 2% to 5% O2 for 35 days) showed elevated blood
pressure occurring after long-term exposure to intermittent hypoxia
(Prabhakar et al., 2001, 2005; Zoccal et al., 2007).
To elucidate the basis for these cardiovascular alterations we
evaluated the effects of CIH, sleep restriction and CIH-sleep restriction
on the renin–angiotensin system. Our results show that hypoxia did
not modify plasma angiotensin I or angiotensin II concentrations.
However, Zoccal et al. (2007) veriﬁed that ganglionic blockade,
combined with antagonism of angiotensin II type 1 receptor (AT1),
produced a decrease in blood pressure in CIH rats. Most likely, the
time of hypoxia (21 days vs. 35 days) and differences in the severity of
hypoxia (5% vs. 10% O2) have an important role in the cardiovascular
response (Li et al., 2007; Perry et al., 2007).
In our study, CIH and sleep restriction markedly reduced plasma
Ang (1–7) concentrations and induced a selective increase in rSNA
activity. We hypothesise that the decrease in Ang (1–7) concentration
after CIH leads to a reduction of its protective effect on the
cardiovascular system. These results suggest that a reduction of Ang
(1–7), a potent vasodilator counters the effects of Ang II, plays a
relevant physiologic role in rSNA and precedes the hypertension in
the CIH group. One hypothesis is that the increase in rSNA may be
triggered by decreased endogenous Ang 1–7 that has been considered
to be a sympathoinhibitory hormone acting in the central nervous
system (Silva et al., 1993). Although this interpretation should be
considered, the complete comprehension of the interactions between
Ang (1–7) and the mechanism that regulates the SNA depends on
several other components. Interestingly, Ang (1–7) concentrations
were higher in the CIH-sleep restricted group compared to CIH.
Moreover, sleep restriction induced an increase in rSNA and a
decrease in plasma Ang (1–7) concentrations. However, there was
no signiﬁcant difference in rSNA in the CIH-sleep restricted group.
Some studies suggest that Ang (1–7) may act as an endogenous
inhibitor of angiotensin II (van der Wouden et al., 2006). Thus, these
data suggest that an increase in Ang (1–7) concentrations induced a
protective effect on the rSNA, thus implying a direct involvement of
Ang (1–7) in cardiovascular control. Probably the ACE2 responsible
for the liberation of Ang (1–7) can be upregulated. We cannot exclude
that other enzymes able to produce Ang (1–7) can be alsoupregulated. Clearly, further studies are needed to elucidate other
mechanisms that modulated SNA.
One hypothesis to explain our data may be attributed to adaptive
responses to hypoxia. Hypoxia is characterised by inadequate oxygen
delivery to tissues resulting in an imbalance between the oxygen
demand and energy supply. Reduction of O2 demand, essential for
breathing and ATP production, leads to the reduction of cellular
activity. Defence mechanisms include erythropoiesis and angiogene-
sis to augment red blood cell mass and oxygen delivery, andmetabolic
remodelling that increases utilisation of oxygen-efﬁcient fuel sub-
strates such as carbohydrates (Hochachka, 1998; Ostadal et al., 1999).
These mechanisms compensated the deleterious effects of intermit-
tent hypoxia. Corroborating the hypothesis noted by Lavie and Lavie
(2006), the age-related decline in mortality in sleep apnea patients
can be explained by the activation of a protective adaptivemechanism
that is inherent to the nature of the syndrome, namely, precondition-
ing. Our data suggest that the decrease in cellular metabolism induced
by both sleep and low O2 concentration may be the reason why
hypoxia during the consolidated sleep period did not have deleterious
effects on the cardiovascular system. Thus, studies speciﬁcally
utilising a stimulus of hypoxia during sleep are necessary to
determine whether the association of hypoxia and disruption of
sleep can independently impact the cardiovascular system.Acknowledgements
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